您已经添加该商品到您的收藏列表
从您收藏列表中删除此商品。
这家公司已成功添加。 查看我的收藏.
这家公司已从你的收藏夹列表中删除。
这家公司已被添加到您的询问车。
这家公司已从询价车中删除。
该商品已被添加到您的询问车。
该商品已经从您的询价车中删除。
商品/公司已达到添加至询价车的数量。
登入NEWPAGES
保持登入状态
每日登录奖励

恭喜! 你获得了今天的每日登录奖励!

5 NP Point这是您获得的奖励!
查看您的每日登录奖励

确保每天回来登入以获更多的奖励!
谢谢!

Back
Seni Jaya Logo
Setia Scientific Solution
Setia Scientific Solution (SA0258107-X)
访客

Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test (Nasopharyngeal Swab)

26-Mar-2024
Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test (Nasopharyngeal Swab)
产品已浏览 8
The Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test (Nasopharyngeal Swab) Combo Rapid Test
(Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of
Covid-19, Influenza A, Influenza B, Respiratory Syncytial Virus(RSV), Adenovirus and
M.pneumoniae antigens in nasopharyngeal swab specimens from individuals with suspected
Covid-19/Influenza/RSV/Adenovirus/M.pneumoniae infection in conjunction with clinical
presentation and the results of other laboratory tests.
Results are for the detection of Covid-19, Influenza A+B, RSV, Adenovirus and M.pneumoniae
antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of
infection. Positive results indicate the presence of correlative antigens, but clinical correlation with
patient history and other diagnostic information is necessary to determine infection status. Positive
results do not rule out other bacterial/viral infection. The agent detected may not be the definite cause
of disease.
Negative results do not preclude Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae infection
and should not be used as the sole basis for treatment or patient management decisions. Negative
results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient
management. Negative results should be considered in the context of a patient’s recent exposures,
history and the presence of clinical signs and symptoms consistent with COVID-19, Influenza A+B,
RSV, Adenovirus and M.pneumoniae.
The Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test is
intended for use by trained clinical laboratory personnel.

DIRECTIONS FOR USE
Allow the test, extracted specimen and/or controls to equilibrate to room temperature (15-30°C)
prior to testing.
1. Remove the test from the sealed foil pouch and use it within one hour. Best results will be obtained if
the test is performed immediately after opening the foil pouch.
2. Invert the specimen collection tube and add 3 drops of the extracted specimen to each of the
specimen well(S) respectively and then start the timer.
3. Wait for the colored line(s) to appear. Read the result at 15 minutes. Do not interpret the result after
20 minutes.


 

Cat. No.

Product Description

Specimen

Format

Kit Size

Cut-Off

Status

IRT-ACO555

Covid-19/Influenza A+B/RSV/Adenovirus/M.pneumoniae
Antigen Combo Rapid Test (Nasopharyngeal Swab)

Nasopharyngeal Swab

Cassette

10 T

See Insert

CE


发信息至 Setia Scientific Solution

谢谢您的询问!
我们的客服会尽快联络您。

如需咨询或问题,联系我们
总办事处

Setia Scientific Solution (SA0258107-X)
Suite 33-01, 33rd Floor, Menara Keck Seng, 203, Jalan Bukit Bintang, 55100 Kuala Lumpur, Malaysia.
Google Maps Waze

电话: +6018-789 7171
传真: +603-3191 3313

邮件: jason@vivogroups.com
网址: https://www.setiascientific.com
网址: https://setiascientific.newpages.com.my/
网址: http://setiascientific.n.my/

Powered by NEWPAGES